Pharmaceutical Companies
Amira Pharmaceuticals to Present Preclinical, Clinical Data from DP2 Receptor Antagonist Program at Pacifichem 2010
Published in Drug Law Weekly, December 28th, 2010
2010 DEC 28 -- Amira Pharmaceuticals, Inc. announced that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
"We are very excited about the two structurally distinct clinical stage molecules, AM211 and AM461," said Peppi Prasit, Ph.D., Chief Scientific Officer. "In particular, the safety and pharmacodynamic readouts displayed by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-12-28)
More Articles from Drug Law Weekly
- Asthma
A benefit of flu: protection from asthma? - Clinical Trials Research
Anacor Pharmaceuticals Announces First Patient Dosed in a Phase 3 Trial of AN2690 For Onychomycosis - Export-Import Bank of the United States
Distributed by the Export-Import Bank of the United States On Behalf of the Independent Office of Inspector General - Biopharmaceuticals
Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
